Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Transcranial Magnetic Stimulation to Treat Parkinson's Disease [Phase 1, Phase 2]
This document reports a completed Phase 1/2 clinical trial evaluating transcranial magnetic stimulation as a treatment for Parkinson disease…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 [Phase 2]
Phase 2 trial evaluating neuroprotection with CoQ10 and GPI-1485 in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia [Phase 2]
Phase 2 trial comparing an implanted neuroprosthesis with sensory training to improve airway protection in chronic dysphagia; results were p…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions [Phase 1]
A Phase 1 bioequivalence study comparing Lupin's ropinirole hydrochloride CR 2 mg tablets to GlaxoSmithKline's REQUIP XL under fed condition…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease. [Phase 4]
Phase 4 clinical trial evaluating methylphenidate for non-motor symptoms and postural control in Parkinson's disease has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan [Phase 2]
A Phase 2 controlled study of ONO-2506PO in Parkinson's disease patients in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease [NA]
A terminated clinical trial investigated whether exercise training improves gait and quality of life in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease [Phase 4]
Phase 4 multicenter placebo-controlled trial evaluating the effect of rasagiline on sleep-wake disturbances in Parkinson's disease; the stud…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Exercise for People With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating exercise for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease [Phase 2]
Phase IIa multicentre study of VR040 in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE [Phase 1, Phase 2]
A clinical trial update outlines an evaluation of CJH1 (CLR4001) for Parkinson's disease across Phase 1 and Phase 2, with the current status…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease [Phase 2]
A Phase 2 single-centre trial evaluating VR040, an inhaled form of apomorphine, in idiopathic Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease [Phase 2, Phase 3]
This document provides an update on a completed Phase 2/3 clinical trial evaluating the efficacy and safety of deferiprone in Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients [Phase 3]
The Phase 3 long-term safety study of KW-6002 (Istradefylline) in Parkinson's disease has completed. The update confirms completion status o…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]
This document provides an update on a completed Phase 2b trial of istradefylline (KW-6002) as add-on therapy to levodopa for Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms [Phase 4]
Phase 4 study evaluating whether DaTSCAN imaging changes clinical management in patients with clinically uncertain parkinsonism or similar s…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease [Phase 2]
A Phase 2 trial of istradefylline (KW-6002) for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 3]
Phase 3 study of KW-6002 (istradefylline) as add-on therapy to levodopa for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Pramipexole Conversion to Ropinirole Controlled Release (CR) [Phase 3]
Phase 3 trial evaluating switching from pramipexole to ropinirole controlled-release in Parkinson disease; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study comparing two formulations of AZD3241 on blood concentrations in healthy volunteers. The trial status is compl…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease [Phase 2]
A Phase 2 double-blind, multicenter, sham-surgery controlled trial of CERE-120 in idiopathic Parkinson's disease has completed with results …
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: GM1 Ganglioside Effects on Parkinson's Disease [Phase 2]
This document reports the completion of a Phase 2 trial evaluating GM1 ganglioside for Parkinson disease, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluating intravenous amantadine for gait freezing in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease [Phase 2]
Phase 2 trial evaluating combined subthalamic nucleus and substantia nigra pars reticulata deep brain stimulation for refractory gait disord…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa [Phase 3]
Phase III randomized trial of ropinirole prolonged-release as adjunctive therapy in Parkinson's disease patients not optimally controlled on…